Deep vein thrombosis of inferior limbs: are thrombolytic agents superior to heparin?
Samama
M M
MM
D000367:Age Factors; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011186:Postphlebitic Syndrome / Q000209:etiology; D013300:Streptokinase / Q000009:adverse effects; D013924:Thrombophlebitis / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase